AllianceRx Walgreens Prime earns URAC reaccreditation for home delivery pharmacyURAC’s full accreditation status means AllianceRx Walgreens Prime’s home delivery services are meeting industry-leading standards. AllianceRx Walgreens Prime highlights financial assistance effortsThe company said it has connected eligible patients to more than $600 million in financial assistance in the past two years. Zydus Cadila receives tentative FDA OK for generic Tagrisso Zydus Cadila's osimertinib provides a generic treatment for lung cancer. Foresee Pharmaceuticals receives FDA nod for Camcevi Camcevi 42 mg subcutaneous injection is a gonadotropin-releasing hormone agonist indicated for the treatment of adult patients with advanced prostate cancer. AllianceRx Walgreens Prime offering hard-to-find HIV medicines The first once-monthly injectable, and oral anti-diarrheal are accessible for adults living with HIV-1. Amber Specialty Pharmacy partners with MarkeTouch Media to enhance care coordination With MarkeTouch Media’s TouchPoint Management solution, Amber Specialty Pharmacy saw improvements in patient adherence, patient experience, and overall satisfaction. Amneal acquires Kashiv Specialty Pharmaceuticals Through the acquisition of Kashiv Specialty Pharmaceuticals, Amneal has gained a pipeline of 505(b)2 branded products and complex generics. Aveo intros oral renal cell carcinoma treatment Fotivda The medication is an oral, next generation vascular endothelial growth factor tyrosine kinase inhibitor. McKesson augments integrated pharmacy services for specialty clinics McKesson’s health system clients will be offered VHRxS’ full suite of specialty pharmacy consulting services. KemPharm gets FDA nod for Azstarys KemPharm's Azstarys is a once-daily product for the treatment of ADHD in patients age 6 years old and older. First Previous 13 14 15 16 17 Next Last
